These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 10912316

  • 1. Ramipril.
    Smith WH, Ball SG.
    Int J Clin Pract; 2000 May; 54(4):255-60. PubMed ID: 10912316
    [Abstract] [Full Text] [Related]

  • 2. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
    Rapezzi C, Ciliberti P, Graziosi M, Riva L.
    Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
    [Abstract] [Full Text] [Related]

  • 3. Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE.
    Gerstein HC.
    Diabetes Metab Res Rev; 2002 Nov; 18 Suppl 3():S82-5. PubMed ID: 12324991
    [Abstract] [Full Text] [Related]

  • 4. The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.
    Can J Cardiol; 1996 Feb; 12(2):127-37. PubMed ID: 8605634
    [Abstract] [Full Text] [Related]

  • 5. Diabetes and the HOPE study: implications for macrovascular and microvascular disease.
    Gerstein HC.
    Int J Clin Pract Suppl; 2001 Jan; (117):8-12. PubMed ID: 11715357
    [Abstract] [Full Text] [Related]

  • 6. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*.
    Schrader J, Lüders S, Kulschewski A, Hammersen F, Züchner C, Venneklaas U, Schrandt G, Schnieders M, Rangoonwala B, Berger J, Dominiak P, Zidek W, MARPLE Study Group.
    J Hypertens; 2006 Mar; 24(3):541-8. PubMed ID: 16467658
    [Abstract] [Full Text] [Related]

  • 7. The HOPE Study (Heart Outcomes Prevention Evaluation).
    Sleight P.
    J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):18-20. PubMed ID: 11967789
    [Abstract] [Full Text] [Related]

  • 8. Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension.
    Bosch J, Lonn E, Pogue J, Arnold JM, Dagenais GR, Yusuf S, HOPE/HOPE-TOO Study Investigators.
    Circulation; 2005 Aug 30; 112(9):1339-46. PubMed ID: 16129815
    [Abstract] [Full Text] [Related]

  • 9. The HOPE (Heart Outcomes Prevention Evaluation) Study and its consequences.
    McQueen MJ, Lonn E, Gerstein HC, Bosch J, Yusuf S.
    Scand J Clin Lab Invest Suppl; 2005 Aug 30; 240():143-56. PubMed ID: 16112972
    [Abstract] [Full Text] [Related]

  • 10. ACE inhibition in cardiovascular disease.
    Francis GS.
    N Engl J Med; 2000 Jan 20; 342(3):201-2. PubMed ID: 10639547
    [No Abstract] [Full Text] [Related]

  • 11. Cardiovascular protection with ace inhibitors--more HOPE for EUROPA?
    Boos CJ.
    Med Sci Monit; 2004 Dec 20; 10(12):SR23-8. PubMed ID: 15567997
    [Abstract] [Full Text] [Related]

  • 12. Ramipril in the treatment of vascular diseases.
    Rokoss MJ, Teo KK.
    Expert Opin Pharmacother; 2005 Sep 20; 6(11):1911-9. PubMed ID: 16144510
    [Abstract] [Full Text] [Related]

  • 13. Current indications for ACE inhibitors and HOPE for the future.
    Burch S, Ou N.
    Am J Manag Care; 2002 May 20; 8(5):478-90; quiz 491-3. PubMed ID: 12019599
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Angiotensin receptor blockers: novel role in high-risk patients.
    Javed U, Deedwania PC.
    Cardiol Clin; 2008 Nov 20; 26(4):507-26. PubMed ID: 18929228
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.
    Lancet; 2000 Jan 22; 355(9200):253-9. PubMed ID: 10675071
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.